Literature DB >> 16416289

Cryptosporidium parvum bovine genotype oocysts in the respiratory samples of an AIDS patient: efficacy of treatment with a combination of azithromycin and paromomycin.

Ahmad-Reza Meamar1, Mostafa Rezaian, Sasan Rezaie, Minoo Mohraz, Eshrat B Kia, Eric R Houpt, Shahram Solaymani-Mohammadi.   

Abstract

Cryptosporidium has been recognized as an emerging zoonotic agent of intestinal cryptosporidiosis leading to diarrhea, malabsorption syndrome, and weight loss in AIDS patients. In the present case, oocysts of zoonotic Cryptosporidium parvum were detected in the sputum and stool samples of an AIDS patient with a 3-month history of intestinal cryptosporidiosis. The oocysts were detected by modified Ziehl-Neelsen staining; confirmation was achieved by nested polymerase chain reaction (PCR), targeting the most polymorphic region of the 18S rRNA gene. Genotyping was done by restriction endonuclease digestion of the PCR product. The zoonotic C. parvum bovine genotype was identified in both intestinal and respiratory samples. Treatment with both azithromycin and paromomycin resulted in improvement of both intestinal and respiratory symptoms, as well as the elimination of the parasite. This is the first report of the identification of Cryptosporidium sp. oocysts in the respiratory samples obtained from an AIDS patient in Iran. Pulmonary cryptosporidiosis should be considered whenever an AIDS patient with intestinal cryptosporidiosis develops respiratory symptoms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16416289     DOI: 10.1007/s00436-005-0097-4

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  17 in total

1.  Prevalence of intestinal parasitic pathogens among HIV-positive individuals in Iran.

Authors:  Mohammad Reza Zali; Ali Jafari Mehr; Mostafa Rezaian; Ahmad Reza Meamar; Siavash Vaziri; Minoo Mohraz
Journal:  Jpn J Infect Dis       Date:  2004-12       Impact factor: 1.362

Review 2.  Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis.

Authors:  J K Griffiths
Journal:  Adv Parasitol       Date:  1998       Impact factor: 3.870

Review 3.  Respiratory cryptosporidiosis: case series and review of the literature.

Authors:  A Clavel; A C Arnal; E C Sánchez; J Cuesta; S Letona; J A Amiguet; F J Castillo; M Varea; R Gómez-Lus
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

4.  Pulmonary cryptosporidiosis in acquired immune deficiency syndrome.

Authors:  E M Brady; M L Margolis; O M Korzeniowski
Journal:  JAMA       Date:  1984-07-06       Impact factor: 56.272

Review 5.  Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients.

Authors:  Paul R Hunter; Gordon Nichols
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  In vitro multiplication of Cryptosporidium parvum in mouse peritoneal macrophages.

Authors:  F Martinez; C Mascaro; M J Rosales; J Diaz; J Cifuentes; A Osuna
Journal:  Vet Parasitol       Date:  1992-04       Impact factor: 2.738

Review 7.  Epidemiology of Cryptosporidium: transmission, detection and identification.

Authors:  R Fayer; U Morgan; S J Upton
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

Review 8.  Cryptosporidium: a water-borne zoonotic parasite.

Authors:  Ronald Fayer
Journal:  Vet Parasitol       Date:  2004-12-09       Impact factor: 2.738

9.  Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virus-infected individuals living in Switzerland, Kenya, and the United States.

Authors:  U Morgan; R Weber; L Xiao; I Sulaiman; R C Thompson; W Ndiritu; A Lal; A Moore; P Deplazes
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 10.  New insights into human cryptosporidiosis.

Authors:  D P Clark
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

View more
  7 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  Molecular characterization of Cryptosporidium isolates from humans and animals in Iran.

Authors:  Ahmad Reza Meamar; Karine Guyot; Gabriela Certad; Eduardo Dei-Cas; Mino Mohraz; Mehdi Mohebali; Kazem Mohammad; Amir Ali Mehbod; Sasan Rezaie; Mostafa Rezaian
Journal:  Appl Environ Microbiol       Date:  2006-12-01       Impact factor: 4.792

3.  Respiratory cryptosporidiosis in HIV-seronegative children in Uganda: potential for respiratory transmission.

Authors:  Siobhan M Mor; James K Tumwine; Grace Ndeezi; Maheswari G Srinivasan; Deogratias H Kaddu-Mulindwa; Saul Tzipori; Jeffrey K Griffiths
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

Review 4.  The evolution of respiratory Cryptosporidiosis: evidence for transmission by inhalation.

Authors:  Jerlyn K Sponseller; Jeffrey K Griffiths; Saul Tzipori
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

5.  Classification of Cryptosporidium species from patients with sporadic cryptosporidiosis by use of sequence-based multilocus analysis following mutation scanning.

Authors:  Aaron R Jex; Aradhana Pangasa; Bronwyn E Campbell; Margaret Whipp; Geoff Hogg; Martha I Sinclair; Melita Stevens; Robin B Gasser
Journal:  J Clin Microbiol       Date:  2008-04-30       Impact factor: 5.948

6.  Cryptosporidium hominis infection of the human respiratory tract.

Authors:  Rubén Mercado; Gregory A Buck; Patricio A Manque; Luiz Shozo Ozaki
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

Review 7.  Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases.

Authors:  Shahram Solaymani-Mohammadi; Lars Eckmann; Steven M Singer
Journal:  Front Cell Infect Microbiol       Date:  2019-12-04       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.